Treatment
Treatment
03/11/2020
The model required community-based pharmacists and HIV medical providers to share patient clinical information, identify therapy-related problems, and develop therapy-related action plans. Learn more about...
03/11/2020
Antiretroviral Therapy
Antiretroviral Therapy
02/18/2020
Because they may be asymptomatic, patients with higher CD4 cell counts who initiate ART are believed to have suboptimal ART adherence and virologic suppression. Findings of a new study appear to rebut this...
02/18/2020
Emerging Infections
Emerging Infections
02/11/2020
New research presented at CROI 2020 identified 3 high-risk behaviors and evaluated them via patient questionnaire among men who have sex with men in New York City.
02/11/2020
HIV
HIV
01/21/2020
Regenerating islet-derived protein 3α is a gut damage marker in inflammatory bowel diseases. Because people with HIV who are taking antiretroviral therapy often present with altered gut microbiota,...
01/21/2020
HIV infection
HIV infection
01/08/2020
Follicular helper T cells are well-known key HIV-1 reservoirs, but are the cells reservoirs for HIV-2 infection as well? A new study investigated.
01/08/2020
Antiretroviral Therapy
Antiretroviral Therapy
12/04/2019
Because the timing of antiretroviral therapy may affect the trajectory of HIV-related inflammation, authors of a new study investigated the effect of early therapy initiation on the cerebrospinal fluid and...
12/04/2019
HIV
HIV
11/22/2019
Because diastolic dysfunction is common among individuals with HIV, authors of the CHART study aimed to evaluate the cardiovascular effects of dysfunction among patients receiving antiretroviral therapy. ...
11/22/2019
Chronic Kidney Disease
Chronic Kidney Disease
11/13/2019
By analyzing results of the multi-cohort Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study, researchers determined whether contemporary protease inhibitors have similar effects on chronic...
11/13/2019
Screening
Screening
11/07/2019
After performance data showed 95% sensitivity and specificity, the FDA authorized the assay’s marketing in the United States for detection of HIV-1 drug-resistant mutations.
11/07/2019
Influenza
Influenza
11/05/2019
For the FLU-IVIG trial, researchers evaluated the safety and efficacy of anti-influenza hyperimmune intravenous immunoglobulin to better understand the clinical benefits for patients with influenza.
11/05/2019